“…In the human breast, Cx43 is expressed in luminal epithelial and myoepithelial compartments, while the expression of Cx26 is restricted to the luminal epithelium [7,8]. Altered expression, localization, and function of Cxs have been reported in human breast cancer tissues and in cell lines [9,10,11,12,13,14,15,16] and have been associated with developmental defects in mouse models [17,18,19], suggesting that Cxs have developmental and tumor suppressive roles. Indeed, Cx43 is proposed as an independent prognostic factor in light of its positive correlation with improved disease outcome in breast cancer patients [20,21].…”